TG Therapeutics Earnings
NASDAQ: TGTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$0.36
TG Therapeutics earnings summary
TG Therapeutics is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $0.36. In its most recent report on Aug 5, 2026 (Q2 2026), TGTX posted EPS of $0.05. Revenue for the quarter was $240.3 million.
Quarterly EPS is down 70.6% from the same quarter a year earlier. Across the last 16 reports, TGTX shares moved an average of 6.9% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
TGTX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.05 | — | -2.0% |
| May 6, 2026 | — | $0.12 | — | -7.8% |
| Feb 27, 2026 | — | $0.14 | — | -2.7% |
| Nov 5, 2025 | — | $2.43 | — | -3.8% |
| Aug 8, 2025 | — | $0.17 | — | +5.1% |
| May 9, 2025 | — | $0.03 | — | +2.1% |
| Mar 3, 2025 | — | $0.16 | — | +6.2% |
| Nov 7, 2024 | — | $0.02 | — | +2.5% |
| Aug 9, 2024 | — | $0.04 | — | +10.8% |
| May 6, 2024 | — | $-0.07 | — | -0.8% |
| Feb 29, 2024 | — | $-0.02 | — | -6.6% |
| Nov 6, 2023 | — | $0.73 | — | +18.1% |
| Aug 4, 2023 | — | $-0.34 | — | -5.4% |
| May 8, 2023 | — | $-0.28 | — | -3.0% |
| Mar 1, 2023 | — | $-0.58 | — | -18.0% |
| Nov 9, 2022 | — | $-0.26 | — | -14.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.